Sanj K. Patel

CIK: 0001532218

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)36 (33.3%)

Position reduction

Option Exercises (M)38 (35.2%)

Derivative conversions

Awards (A)18 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)16 (14.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

KNSA

Kiniksa Pharmaceuticals International, plc

Discretionary Trading P&L

Holdings

Transaction History (108 total)

KNSA
Kiniksa Pharmaceuticals International, plc
Nov 3, 2026
Sale(S)
Indirect
68.7K shares at avg. $92.70$6.4M
KNSA
Kiniksa Pharmaceuticals International, plc
Nov 3, 2026
Sale(S)
Indirect
1.2K shares at avg. $90.77$110K
KNSA
Kiniksa Pharmaceuticals International, plc
Nov 3, 2026
Exercise(M)
Indirect
41.2K shares at avg. $17.92$739K
KNSA
Kiniksa Pharmaceuticals International, plc
Nov 3, 2026
Sale(S)
Indirect
4.6K shares at avg. $94.25$432K
KNSA
Kiniksa Pharmaceuticals International, plc
Nov 3, 2026
Exercise(M)
Indirect
89.1K shares at avg. $8.83$787K
KNSA
Kiniksa Pharmaceuticals International, plc
Nov 3, 2026
Sale(S)
Indirect
145.7K shares at avg. $93.53$13.6M
KNSA
Kiniksa Pharmaceuticals International, plc
Nov 2, 2026
Sale(S)
Indirect
38.4K shares at avg. $91.03$3.5M
KNSA
Kiniksa Pharmaceuticals International, plc
Nov 2, 2026
Exercise(M)
Indirect
53.4K shares at avg. $8.83$471K
KNSA
Kiniksa Pharmaceuticals International, plc
Nov 2, 2026
Sale(S)
Indirect
24.2K shares at avg. $91.83$2.2M
KNSA
Kiniksa Pharmaceuticals International, plc
Nov 2, 2026
Sale(S)
Indirect
26.8K shares at avg. $93.06$2.5M
KNSA
Kiniksa Pharmaceuticals International, plc
Nov 2, 2026
Sale(S)
Indirect
100 shares at avg. $93.97$9K
KNSA
Kiniksa Pharmaceuticals International, plc
Oct 30, 2026
Exercise(M)
Indirect
47.5K shares at avg. $8.83$420K
KNSA
Kiniksa Pharmaceuticals International, plc
Oct 30, 2026
Sale(S)
Indirect
18.7K shares at avg. $92.77$1.7M
KNSA
Kiniksa Pharmaceuticals International, plc
Oct 30, 2026
Sale(S)
Indirect
15.9K shares at avg. $93.62$1.5M
KNSA
Kiniksa Pharmaceuticals International, plc
Oct 30, 2026
Sale(S)
Indirect
8.9K shares at avg. $94.72$842K
KNSA
Kiniksa Pharmaceuticals International, plc
Oct 30, 2026
Sale(S)
Indirect
4.5K shares at avg. $95.97$431K
KNSA
Kiniksa Pharmaceuticals International, plc
Oct 30, 2026
Sale(S)
Indirect
41.2K shares at avg. $92.01$3.8M
KNSA
Kiniksa Pharmaceuticals International, plc
Oct 30, 2026
Sale(S)
Indirect
2.3K shares at avg. $97.34$225K
KNSA
Kiniksa Pharmaceuticals International, plc
Oct 30, 2026
Sale(S)
Indirect
1.4K shares at avg. $98.16$141K
KNSA
Kiniksa Pharmaceuticals International, plc
Sep 1, 2026
Exercise(M)
Indirect
6.5K shares-
KNSA
Kiniksa Pharmaceuticals International, plc
Sep 1, 2026
Exercise(M)
Indirect
8.6K shares-
KNSA
Kiniksa Pharmaceuticals International, plc
Sep 1, 2026
Exercise(M)
Indirect
10K shares-
KNSA
Kiniksa Pharmaceuticals International, plc
Sep 1, 2026
Exercise(M)
Indirect
6.2K shares-
KNSA
Kiniksa Pharmaceuticals International, plc
Sep 1, 2026
Tax Payment(F)
Indirect
15.1K shares at avg. $79.28$1.2M
KNSA
Kiniksa Pharmaceuticals International, plc
Sep 1, 2026
Award(A)
Restricted Share Unit
Direct
30.1K shares-

		Type	Shares	Price		Ownership
Nov 3, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Sale(S)	68,664	$92.70	$6,365,153	Indirect
Nov 3, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Sale(S)	1,214	$90.77	$110,195	Indirect
Nov 3, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Exercise(M)	41,237	$17.92	$738,967	Indirect
Nov 3, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Sale(S)	4,584	$94.25	$432,042	Indirect
Nov 3, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Exercise(M)	89,089	$8.83	$786,656	Indirect
Nov 3, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Sale(S)	145,708	$93.53	$13,628,069	Indirect
Nov 2, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Sale(S)	38,364	$91.03	$3,492,275	Indirect
Nov 2, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Exercise(M)	53,381	$8.83	$471,354	Indirect
Nov 2, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Sale(S)	24,188	$91.83	$2,221,184	Indirect
Nov 2, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Sale(S)	26,781	$93.06	$2,492,240	Indirect
Nov 2, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Sale(S)	100	$93.97	$9,397	Indirect
Oct 30, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Exercise(M)	47,530	$8.83	$419,690	Indirect
Oct 30, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Sale(S)	18,685	$92.77	$1,733,407	Indirect
Oct 30, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Sale(S)	15,903	$93.62	$1,488,839	Indirect
Oct 30, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Sale(S)	8,888	$94.72	$841,871	Indirect
Oct 30, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Sale(S)	4,490	$95.97	$430,905	Indirect
Oct 30, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Sale(S)	41,169	$92.01	$3,787,960	Indirect
Oct 30, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Sale(S)	2,316	$97.34	$225,439	Indirect
Oct 30, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Sale(S)	1,440	$98.16	$141,350	Indirect
Sep 1, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Exercise(M)	6,481	-	$0	Indirect
Sep 1, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Exercise(M)	8,609	-	$0	Indirect
Sep 1, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Exercise(M)	9,991	-	$0	Indirect
Sep 1, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Exercise(M)	6,237	-	$0	Indirect
Sep 1, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Tax Payment(F)	15,144	$79.28	$1,200,616	Indirect
Sep 1, 2026	KNSA Kiniksa Pharmaceuticals International, plc	Award(A) Restricted Share Unit	30,050	-	-	Direct

1-25 of 108 transactions

About Patel Sanj K

Patel Sanj K (SEC CIK 0001532218) files insider reports with the SEC as CHAIRMAN & CEO of Kiniksa Pharmaceuticals International, plc (KNSA).

Signal8 holds 21 ownership filings by Patel Sanj K, all Form 4s, filed between Sep 4, 2024 and Nov 3, 2026. Those filings report 108 transactions, from Sep 1, 2024 to Nov 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Patel Sanj K's filings is in LONDON.

Recent filings by Patel Sanj K

Nov 3, 2026: Open-market sales of KNSA shares (2 lines, Form 4, code S).
Nov 3, 2026: Option exercise of KNSA shares (Form 4, code M).
Nov 3, 2026: Open-market sale of KNSA shares (Form 4, code S).
Nov 3, 2026: Option exercise of KNSA shares (Form 4, code M).
Nov 3, 2026: Open-market sale of KNSA shares (Form 4, code S).

Other insiders filing for Kiniksa Pharmaceuticals International, plc (KNSA)

Ragosa Mark, CHIEF FINANCIAL OFFICER
Paolini John F., CHIEF MEDICAL OFFICER
Moat Ross, CHIEF OPERATING OFFICER
Megna Michael R, CHIEF ACCOUNTING OFFICER
Quart Barry D, Director
Levy Richard S, Director

How to read Form 4 transaction codes